Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimization of Maxomat Administration in IUGR
NCT00452491Phase 3Completed
- Sponsor
- Sanofi
- Start
- May 1993
- Primary completion
- Apr 2010
- Countries
- 1
01
Overview
A Phase 3 trial of somatropin in Intrauterine Growth Restriction (IUGR), sponsored by Sanofi. Started May 1993; status: completed.
02
Drugs
somatropin
03
Conditions
Intrauterine Growth Restriction (IUGR)
Beyond the preview
Go deeper on NCT00452491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00452491.